Bioactive lipids in schizophrenia (Q33246888)

24 July 2017

1 reference

title

Bioactive lipids in schizophrenia (English)

1 reference

24 July 2017

0 references

0 references

2

Stefan Smesny

1 reference

24 July 2017

Gregor E Berger

1

1 reference

24 July 2017

G Paul Amminger

series ordinal

3

1 reference

24 July 2017

publication date

1 April 2006

1 reference

International Review of Psychiatry

24 July 2017

published in

1 reference

24 July 2017

volume

18

1 reference

24 July 2017

issue

2

1 reference

24 July 2017

page(s)

85-98

1 reference

Lipid signaling in neural plasticity, brain repair, and neuroprotection

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Bioactive lipids in excitatory neurotransmission and neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Implications of lipid biology for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Fat consumption and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

White matter changes in schizophrenia: evidence for myelin-related dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Is schizophrenia a lifetime disorder of brain plasticity, growth and aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Determination of fatty acids in cerebrospinal fluid. V. The fatty acid content in the total lipids of cerebrospinal fluid in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Organelle-specific initiation of cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Phospholipase A2 and the hypofrontality hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Increased platelet phospholipase A2 activity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Is low dietary intake of omega-3 fatty acids associated with depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Histamine and prostaglandins in schizophrenia: revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Fish consumption and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Adverse Effects of Niacin In Emergent Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Schizophrenia as a membrane lipid disorder which is expressed throughout the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Fatty acid levels in the brains of schizophrenics and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Schizophrenia as a prostaglandin deficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Genetic variant near cytosolic phospholipase A2 associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Neonatal polyunsaturated fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Epidemiology of schizophrenia: the global burden of disease and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Erythrocyte membrane phospholipids in psychotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Phosphorus 31 Magnetic Resonance Spectroscopy Detects Altered Brain Metabolism Before Onset of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Incidence of cancer among persons with schizophrenia and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

The Nithsdale Schizophrenia Surveys. 16. Breast-feeding and schizophrenia: preliminary results and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Advice to eat fish and mood: a randomised controlled trial in men with angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Elevated PLA2 activity in schizophrenics and other psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

At issue: schizophrenia and rheumatoid arthritis: the negative association revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Volatile organic compounds in the breath of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Eicosapentaenoic acid in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Apolipoprotein E in schizophrenia: a French association study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

The expanding superfamily of phospholipase A(2) enzymes: classification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Increased phospholipase A2 activity in schizophrenia with absent response to niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Magnetic resonance spectroscopy and schizophrenia: what have we learnt?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

No association between breast-feeding and adult psychosis in two national birth cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260600583072

10.1080/09540260600583072

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference